Arcadia Biosciences Income Statement - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.7 $0.01 (1.27%) RKDA stock closing price Apr 26, 2017 (Closing)

Financial analysis of Arcadia Biosciences involves more than just checking the Arcadia Biosciences stock price, by looking at the financial statements of the company in detail. The income statement is a summary of the revenue, expenses and profitability (shown as Net Income) or lack of it. The income statement for RKDA which implies a QoQ revenue decline of $0.54M is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Arcadia Biosciences assets and Arcadia Biosciences free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have decreased from $-4.18M QoQ and 2016-Q4 revenue is $0.54M. View details of revenue and profits for Arcadia Biosciences for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3
Arcadia Biosciences Net Sales or Revenues
0.54M1.08M0.72M0.85M1.35M1.82M1.43M0.82M2.8M1.5M
Cost Of Goods Sold (COGS)0.66M0.06M0.03M0.14M0.68M0.06M0.1M0.05M0.07M1.79M
Arcadia Biosciences Gross Profit
-0.1M1.01M0.68M0.7M0.69M1.76M1.32M0.75M2.74M-0.29M
Research & Development Expense2M2.25M2.21M2.2M1.88M3.17M2.08M1.83M2.08M3.68M
Selling General & Admin Expense3.39M2.68M2.75M3.43M2.89M2.81M2.78M2.63M2.3M1.96M
Income Before Depreciation Depletion Amortization-5.49M-3.92M-4.28M-4.93M-4.08M-4.23M-3.54M-3.71M-1.64M-5.94M
Depreciation Depletion Amortization----------
Non Operating Income0.11M0.09M0.07M0.07M0.67M0.28M0.73M-1.39M0.02M-0.81M
Interest Expense0.34M0.33M0.32M0.32M0.66M0.76M0.77M0.46M0.36M0.26M
Arcadia Biosciences Pretax Income
-5.71M-4.16M-4.54M-5.18M-4.07M-4.71M-3.58M-5.57M-1.97M-7.02M
Provision for Income Taxes-0.01M0.01M0.01M-0.2M-0.09M0.09M0.22M0.04M0.04M
Minority Interest----------
Investment Gains Losses---------0.01M-
Other Income----------
Income Before Extraordinaries & Disc Operations-5.71M-4.18M-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M-7.06M
Extraordinary Items & Discontinued Operations----------
Arcadia Biosciences Net Income (Profit/Loss)
-5.71M-4.18M-4.55M-5.19M-3.86M-4.62M-3.68M-5.8M-1.99M-7.06M
Average Shares used to compute Diluted EPS43.91M44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M
Average Shares used to compute Basic EPS43.91M44.37M44.31M44.22M44.11M43.65M23.78M2.08M2.07M2.06M
Income Before Nonrecurring Items-5.71M-4.18M-4.55M-5.19M-3.63M-4.62M-3.68M-5.8M-1.99M-7.06M
Income from Nonrecurring Items-----0.23M-----
Arcadia Biosciences Earnings Per Share Basic Net
-0.13-0.09-0.10-0.12-0.09-0.11-0.19-3.71-1.76-4.19
Arcadia Biosciences Earnings Per Share Diluted Net
-0.13-0.09-0.10-0.12-0.09-0.11-0.19-3.71-1.76-4.19
EPS Diluted Before Nonrecurring Items-0.13-0.09-0.10-0.12-0.08-0.11-0.19-3.71-1.76-4.19
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common----------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Income statement for another ticker

The key things to look for in an income statement while doing Arcadia Biosciences stock analysis are:
  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth (See: Arcadia Biosciences revenue chart) implies that the company is growing, which has not been the case with Arcadia Biosciences. One must stay away from stocks whose revenues are declining.
  • Bottom line: The Bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $0.54M - other expenses = $-5.71M for RKDA stock. An improving bottomline implies that the company is growing profits.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Arcadia Biosciences historical stock prices to check how the price has moved with time. .

Arcadia Biosciences Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
9.6492
Operating margin
-1016.7
Net profit margin
-1057.4
Dividend yield
0%

Other Income Statements - Arcadia Biosciences Inc Industry Peers

The Andersons income statement, DuPont income statement, Dow Chemical income statement, Monsanto income statement